Japan Diagnostics Lab Market to Be Dominated by Type Pathology Till 2027
Extensive foreign direct
investments for the development of healthcare industry and growing old age
population are estimated to support the growth of Japan diagnostic labs in the
forecast period, 2023-2027.
According to TechSci Research report, “Japan Diagnostics Lab Market - By Region,
Competition Forecast & Opportunities, 2027”, the Japan Diagnostics Lab market is expected to witness
growth at a significant rate in 2023-2027. Diagnostic labs represent the center
in which various tests and medical tests are performed as per the requirement
of the patient to help in detecting or diagnosis of any disease. These tests
aid in the controlling, surveillance, and prevention of any infectious or
chronic disease. Diagnostic tests help in improving patient care and reducing
healthcare spending. Japan has an advanced healthcare sector that continuously
focus on technological evolution to fulfil the growing testing requirements.
The escalating demand for point-of-care devices among patients and the
government support to improve the healthcare infrastructure are driving the
demand for the diagnostics lab market across Japan. Continuous evolutions are
occurring in the field of medicine, especially in diagnostic laboratory
services, and advanced techniques are being discovered at a regular pace. This
further propelled substantial number of people to work in this industry, which
results into pushing the diagnostic laboratory services market to gain
boundless growth. Many people are gradually getting aware of the immense
advantages provided by quality diagnostic services when it comes to
understanding and treating ailments. All these aforementioned factors are
expected to support the market growth in the forthcoming years.
The growing geriatric population who are
more prone to immunological disorders and the need of the services of
diagnostic labs for early disease diagnosis accelerates the market growth.
Additionally, the rising awareness about the benefits of personalized medicines
to treat chronic diseases, such as cancer, is anticipated to bolster the growth
of the diagnostics labs market for the next five years.
However, the implementation of stringent
government regulations and inadequate reimbursement policies are limiting the
growth of Japan diagnostics lab market in the upcoming years.
Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on "JAPAN DIAGNOSTICS LAB MARKET"
The Japan diagnostic labs market is segmented
into provider type, test type, end user, regional distribution, and competitive
landscape.
Based on provider type, the market is
divided into hospital, stand-alone center, and diagnostic chains. Diagnostic
chains are anticipated to hold the significant market share in the forecast
period, 2023-2027. Stringent pricing norms set up by the government authorities
and the inflating per capita income stimulates the need for advanced tests and
procedures from diagnostic chains.
Based on test type, the market is
divided into radiology and pathology. The pathology segment is expected to
dominate the Japan diagnostic labs market for the forthcoming years. An
increase in awareness among individuals towards medical testing and early
diseases detection is projected to propel the demand for diagnostic labs across
Malaysia. Pathology offers alternatives as it supports home-based testing and
testing at the lab center. The growing awareness about the benefits of using
diagnostic labs in the country and the option to opt for the testing type as per
the patient preference will continue to bolster the segment growth over the
forecast period.
Based on end-user, the market is divided
into corporate clients, walk-ins, and referrals. The corporate client segment
is expected to account for a largest market share in the forecast period. The
rise in the adoption of diagnostic labs, especially during COVID-19, to prevent
the spread of novel coronavirus in corporate offices accelerated the segment
growth from corporate offices.
Leading market players operating in the Japan
diagnostics lab market are:
- Miraca Holdings Inc.
- Eurofins Scientific (Genetic Lab)
- BML, Inc.
- Forest Japan Medical Centre
- H.U. Group
DOWNLOAD FREE SAMPLE REPORT
Customers
can also request for 10% free customization on this report.
“The improving focus of market players on the
development of advanced diagnostic labs and the integration of new technologies
to augments the accuracy of medical testing is expected to positively influence
the market growth. The emerging trend of lab automation and the introduction of
numerous specialized tests for early disease diagnosis and management are
revolutionizing the diagnostic labs market across Japan. The increase in the
prevalence of lifestyle diseases, including atherosclerosis, cardiovascular
disease, and stroke, and the supportive government policies promoting the
healthcare industry is anticipated
to fuel the Japan diagnostics lab market growth till 2027” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based global
management consulting firm”.
“Japan Diagnostics Lab Market
By Provider Type (Hospital, Stand-Alone Centre, Diagnostic Chains), By Test
Type (Radiology v/s Pathology), By End User (Corporate Clients, Walk-ins,
Referrals), By Region, Competition Forecast & Opportunities, 2027” has analyzed the future growth potential
of Japan diagnostics lab market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and assist decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with significant drivers, challenges, and opportunities
in Japan diagnostics lab market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com